SCF ENCYCLOPEDIA ENTRY

WILSON DISEASE

SCF COPPER HOMEOSTASIS FAILURE & HEPATONEUROLOGIC METAL TOXICITY DOSSIER

I. OFFICIAL DISEASE CLASSIFICATION

Wilson Disease belongs to SCF Clinical Domains C3 (Hepatic Biology), C7 (Neurology), C1 (Genomic Medicine), C5 (Metabolic Biology), and C6 (Cellular Systems Biology).

II. CLINICAL DEFINITION

Wilson Disease is an autosomal recessive disorder characterized by:

• Excessive copper accumulation
• Impaired biliary copper excretion
• Hepatic injury
• Neurologic degeneration
• Psychiatric manifestations

Primary affected systems:

• Liver
• Basal ganglia
• Brainstem
• Cornea
• Kidneys
• Endocrine organs

Associated conditions:

• Cirrhosis
• Acute liver failure

III. BIOLOGICAL FOUNDATION

Normal Copper Physiology

Copper is required for:

• Mitochondrial respiration
• Neurotransmitter synthesis
• Antioxidant defense
• Connective tissue formation
• Iron metabolism

Associated concept:

• Copper homeostasis

ATP7B Function

ATP7B is responsible for:

1. Copper incorporation into ceruloplasmin
2. Copper excretion into bile

Normal relationship:

$ATP7B\Rightarrow Biliary\ Copper\ Excretion\Rightarrow Copper\ Homeostasis$

IV. GENETIC ETIOLOGY

Primary Gene

Chromosomal location:

• Chromosome 13q14.3

Inheritance:

Associated concept:

• ATP7B

V. CORE SCF ETIOPATHOGENIC THESIS

Within SCF, Wilson Disease represents a systems-level collapse of:

• Trace-metal regulation
• Hepatic detoxification architecture
• Cellular redox balance
• Neuroprotective metal handling
• Metabolic waste export

SCF interprets Wilson Disease as a copper-congestion syndrome in which essential trace metals become toxic because biological export pathways fail.

VI. CORE PATHOPHYSIOLOGIC MECHANISMS

Hepatic Copper Accumulation

ATP7B deficiency causes:

• Reduced biliary excretion
• Copper retention
• Hepatocyte injury

Disease sequence:

$ATP7B\ Deficiency\Rightarrow Copper\ Retention\Rightarrow Hepatic\ Toxicity$

Systemic Redistribution

As liver storage capacity becomes overwhelmed:

Copper spreads to:

• Brain
• Cornea
• Kidneys
• Heart

Result:

• Progressive multisystem toxicity

VII. COPPER TOXICITY BIOLOGY

Cellular Injury Mechanisms

Copper excess causes:

• Oxidative stress
• Lipid peroxidation
• Protein damage
• DNA injury
• Mitochondrial dysfunction

Associated concept:

• Oxidative stress

Neurologic Vulnerability

Particularly affected:

• Basal ganglia
• Putamen
• Globus pallidus
• Thalamus

Associated condition:

• Basal ganglia degeneration

VIII. SCF FAULT ARCHITECTURE

IX. MULTI-OMICS PATHOGENESIS

A. Genomics

Affected pathways:

• Metal transport
• Hepatic metabolism
• Cellular detoxification
• Oxidative defense

B. Transcriptomics

Dysregulated pathways:

• Stress-response signaling
• Mitochondrial regulation
• Inflammatory cascades
• Cell-survival mechanisms

C. Proteomics

Observed abnormalities:

• Ceruloplasmin reduction
• ATP7B dysfunction
• Oxidative stress proteins
• Mitochondrial proteins

D. Metallomics

Characteristic findings:

• Elevated hepatic copper
• Elevated urinary copper
• Tissue copper redistribution

Associated concept:

• Metallomics

E. Toxicometabolomics (SCF)

Observed abnormalities:

• Copper congestion
• Detoxification failure
• Oxidative overload
• Metabolic stress

X. SCF PATHOGENESIS FLOW

Stage 1 — ATP7B Dysfunction

Copper export becomes impaired.

Stage 2 — Hepatic Retention

Copper accumulates within hepatocytes.

Stage 3 — Oxidative Injury

Cellular damage develops.

Stage 4 — Liver Dysfunction

Inflammation and fibrosis emerge.

Stage 5 — Systemic Redistribution

Copper spreads beyond the liver.

Stage 6 — Multisystem Disease

Neurologic and psychiatric manifestations develop.

XI. SYSTEMIC CONSEQUENCES

Hepatic Manifestations

Common findings:

• Hepatitis
• Cirrhosis
• Liver failure

Associated conditions:

• Chronic hepatitis
• Portal hypertension

Neurologic Manifestations

Common findings:

• Tremor
• Dystonia
• Dysarthria
• Parkinsonism
• Ataxia

Associated conditions:

• Dystonia
• Parkinsonism

Psychiatric Manifestations

Common findings:

• Depression
• Anxiety
• Personality changes
• Cognitive dysfunction

Associated conditions:

• Major depressive disorder
• Anxiety disorder

Ophthalmologic Manifestations

Hallmark finding:

• Kayser–Fleischer rings

XII. RHENOVA INTERPRETATION

Project RHENOVA interprets Wilson Disease as a biologic heavy-metal logistics failure.

RHENOVA Dynamics

• Copper transport bottleneck
• Hepatic storage overload
• Toxic redistribution
• Systemic contamination
• Progressive organ failure

RHENOVA Biomarkers

XIII. DBI INTERPRETATION

The SCF Decentralized Biological Intelligence framework interprets copper metabolism as a regulated resource-management network.

Normal functions:

• Metal allocation
• Resource distribution
• Toxicity prevention
• Cellular support
• Waste export

DBI Failure Features

• Resource congestion
• Storage overload
• Export failure
• Toxic redistribution

A normally beneficial trace metal becomes a network-wide toxic burden.

XIV. CLINICAL MANIFESTATIONS

Hepatic Presentation

Common findings:

• Elevated liver enzymes
• Hepatomegaly
• Jaundice
• Liver failure

Associated condition:

• Jaundice

Neurologic Presentation

Common findings:

• Tremor
• Slurred speech
• Poor coordination
• Rigidity

Associated condition:

• Ataxia

Psychiatric Presentation

Common findings:

• Behavioral changes
• Depression
• Impulsivity
• Mood instability

XV. DIAGNOSTICS

Diagnostic Hallmarks

Metal regulation principle:

$ATP7B\ Dysfunction\Rightarrow Copper\ Accumulation$

Biologic relationship:

$Copper\ Overload\Rightarrow Oxidative\ Injury$

Clinical consequence:

$Copper\ Toxicity\Rightarrow Hepatoneurologic\ Disease$

XVI. STANDARD OF CARE

Copper Chelation Therapy

Common medications:

• Penicillamine
• Trientine

Copper Absorption Reduction

Common therapy:

• Zinc acetate

Advanced Disease

Potential intervention:

• Liver transplantation

XVII. SCF-PCR THERAPEUTIC ARCHITECTURE

Preventative (PCR-P)

Goals:

• Family screening
• Early diagnosis
• Copper accumulation prevention

Curative (PCR-C)

Future goals:

• ATP7B gene replacement
• Copper transport restoration
• Precision metallomic correction

Restorative (PCR-R)

Goals:

• Preserve liver function
• Protect neurologic integrity
• Restore copper homeostasis
• Re-establish detoxification synchronization

XVIII. ETHNOBIOPROSPECTING TARGETS

Important: No botanical intervention replaces copper chelation therapy, zinc therapy, or liver transplantation.

Research domains include hepatoprotective, antioxidant, and mitochondrial-support pathways.

Traditional Chinese Medicine

• Schisandra chinensis
• Salvia miltiorrhiza

Ayurveda

• Phyllanthus amarus
• Picrorhiza kurroa

Vietnamese Thuốc Nam

• Phyllanthus urinaria
• Centella asiatica

XIX. SCF API DISCOVERY TARGETS

1. ATP7B gene-replacement therapies
2. Precision copper-export restoration systems
3. Copper-binding biologics
4. Metallomic homeostasis regulators
5. Hepatoprotective regenerative therapies
6. Neuroprotective anti-copper toxicity platforms
7. Metal-detoxification synchronization technologies

XX. SCF LAYMAN’S SUMMARY

Wilson Disease is an inherited disorder in which the body cannot properly eliminate excess copper. Because the ATP7B copper-transport system is defective, copper accumulates first in the liver and later in the brain, eyes, and other organs. Over time this causes liver disease, movement disorders, psychiatric symptoms, and characteristic Kayser–Fleischer rings in the eyes. Modern treatment with copper-chelating medications and zinc can prevent serious complications when started early. SCF interprets Wilson Disease as a trace-metal congestion syndrome in which failure of copper-export pathways transforms a necessary nutrient into a toxic systemic burden.

XXI. STRATEGIC RESEARCH PRIORITIES

1. ATP7B gene therapy
2. Copper-export restoration platforms
3. Precision metallomic regulation technologies
4. Mitochondrial-protection strategies
5. Neuroprotective copper-detoxification systems
6. Hepatic regenerative therapies
7. Metal-homeostasis synchronization restoration science

MASTER REGISTRY INDEX

SCF-WILSON-0001 — Wilson Disease Master Registry

SCF-WILSON-ATP7B-0002 — Copper Transport Failure Layer

SCF-WILSON-METALLOMICS-0003 — Copper Homeostasis Collapse Layer

SCF-WILSON-HEPATONEUROLOGY-0004 — Hepatic & Neurologic Toxicity Layer

SCF-WILSON-RHENOVA-0005 — Metal Logistics Failure Layer

SCF-WILSON-DBI-0006 — Resource Distribution Network Failure Layer

SCF-WILSON-PCR-0007 — Preventative–Curative–Restorative Layer